Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : MAJOR PHARMACEUTICALS
REPLIGEN CORP.
Repligen Corp.
XNAS: RGEN
Momentum Trap
Download real time
123.56
-0.65
(
-0.52
%)
32.30% Fall from 52W High
851.5K
XNAS Volume
XNAS
27 Jun, 2025 5:30 PM (EDT)
Watchlist
Portfolio
Alert
Share
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
My Notes
Overview
Buy Sell Zone
Financials
Technicals
Share Price History
Ownership
Insider Deals
Corporate Actions
All
Dividend
Split
Board Meetings
About
Repligen Corp. - RGEN - stock price prediction, stock price target, analyst ratings from 20 analysts
Repligen Corp. has a share price target of US$ 181, revenue growth forecast of 11.8%, and profit growth estimate of 280.9% for FY25, based on top 20 analyst calls.
Forecaster Screeners